0001104659-13-091208.txt : 20131219 0001104659-13-091208.hdr.sgml : 20131219 20131219155142 ACCESSION NUMBER: 0001104659-13-091208 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131219 DATE AS OF CHANGE: 20131219 EFFECTIVENESS DATE: 20131219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORR-JENSEN INC. CENTRAL INDEX KEY: 0001594744 IRS NUMBER: 260766862 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-208353 FILM NUMBER: 131288330 BUSINESS ADDRESS: STREET 1: 221 SOUTH CHEROKEE STREET CITY: DENVER STATE: CO ZIP: 80223 BUSINESS PHONE: 303-468-4215 MAIL ADDRESS: STREET 1: 221 SOUTH CHEROKEE STREET CITY: DENVER STATE: CO ZIP: 80223 D 1 primary_doc.xml X0707 D LIVE 0001594744 CORR-JENSEN INC. 221 South Cherokee Street Denver CO COLORADO 80223 (303) 468-4215 COLORADO Evolution Pharmaceuticals, Inc. Corr-Jensen Labs, Inc. None Corporation true Matthew Tartaglia 560 Broadway, Suite 604 New York NY NEW YORK 10012 Executive Officer Matthew Hesse 221 South Cherokee Street Denver CO COLORADO 80223 Executive Officer Director Charles Mechem 221 South Cherokee Street Denver CO COLORADO 80223 Director Other $5,000,001 - $25,000,000 06b false 2013-12-06 false true false 0 2004061 200000 1804061 false 1 0 0 0 true CORR-JENSEN INC. /s/ Matthew Hesse Matthew Hesse Chief Executive Officer 2012-12-19